VeriMomIst anthemis nobilis flower extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
Pregnancy-safe products containing anthemis nobilis flower extract
Related ingredients
Frequently asked questions
- Ist anthemis nobilis flower extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
- Ist anthemis nobilis flower extract während des Stillens sicher?
- No evidence of maternal reproductive or lactation toxicity or harmonised classification. No specific data showing transfer into breast milk for the extract; topical use implies low but measurable systemic exposure, so low exposure during breastfeeding is plausible. Sources: absence of reproductive/lactation hazard in ECHA/CIR listings and general safety literature (PubChem, EWG).
- Ist anthemis nobilis flower extract sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data identified for the extract; no harmonised classification. Because infant skin has higher permeability and surface-area-to-weight ratio, exposure rating is increased by one step versus adult (adult e=1 → infant e=2). Clinical concerns for chamomile are primarily topical allergy in sensitive individuals, not developmental toxicity. Sources: ECHA Annex VI (no classification), PubMed/CIR absence of developmental signals, EWG.
- Wie bewertet VeriMom anthemis nobilis flower extract?
- VeriMom bewertet anthemis nobilis flower extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu anthemis nobilis flower extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu anthemis nobilis flower extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.